Melky Cabrera bought a website and dreamed up a fake supplement in an attempt to beat his PED suspension

90 Comments

This all reads like the plot for a low-budget tech thriller movie. A bad, low-budget tech thriller.

According to Teri Thompson, Bill Madden, Christian Red, Michael O’Keefe and Nathaniel Vinton of the New York Daily News, outfielder Melky Cabrera “created a fictitious website and a nonexistent product designed to prove he inadvertently took the banned substance that caused a positive test under Major League Baseball’s drug program.”

The website, purchased by an associate of Cabrera’s from the Dominican Republic named Juan Nunez, cost a total of $10,000.

The product, advertised as a topical cream, was going to anchor Cabrera’s defense during his appeal.

But “baseball figured out the ruse pretty quickly,” a source familiar with the case told the Daily News.

Cabrera’s agents, Sam and Seth Levinson of ACES, have distanced themselves from Nunez and are claiming that the scheme was concocted without their knowledge. There’s no evidence that they’re lying, though Nunez has been hired directly by the agents in the past to obtain and deal with Dominican clients.

Federal investigators are now looking into the case, and it seems possible if not likely that Cabrera will be facing punishment beyond his 50-game ban from professional baseball. “If you engage in this type of activity,” concludes a well-informed source in the Daily News exclusive, “you do it at great risk to your livelihood.”

Athletics place Sean Manaea on disabled list with a left shoulder strain

Getty Images
Leave a comment

The Athletics placed left-hander Sean Manaea on the 10-day disabled list with a shoulder strain, according to a team announcement on Sunday. The move is retroactive to April 27, when Manaea was lifted from his last start after experiencing shoulder tightness. Manager Bob Melvin told reporters that he only expects Manea to miss one start during his stint on the DL, as the team is planning to utilize right-hander Sonny Gray in his place on Tuesday.

Manaea, 25, has yet to find his footing in his sophomore season with the Athletics. Over five starts, including his abbreviated outing against the Angels last Wednesday, the left-hander carries a 5.18 ERA, 3.28 FIP and 10.0 SO/9 through 24 1/3 innings. Even when healthy, control issues have spoiled some of his more dominant outings, doubling his walk rate per nine innings from the 2.2 BB/9 mark he posted during his rookie season in 2016.

With Manaea due back in the rotation by May 7, the A’s will eventually need to clear roster space to accommodate him. Susan Slusser of the San Francisco Chronicle speculates that the decision could come down to right-handers Jesse Hahn and Jharel Cotton, though the team is still several days away from any formal announcement. Cotton has looked like two wildly different pitchers over his last five starts, tossing two-hit shutouts on his good days and getting shelled with 5-6 runs on his bad days. Hahn, meanwhile, has been a steadier presence in Oakland’s rotation, and his 2.08 ERA and eight-inning shutout should keep him in the majors a while longer, especially if he can replicate those results against the Astros on Sunday.

Noah Syndergaard refused an MRI for his sore biceps

Getty Images
6 Comments

Mets’ right-hander Noah Syndergaard will take the hill on Sunday afternoon, just three days after he was scratched from a start due to right biceps tendinitis and shoulder discomfort. Syndergaard told reporters that he refused recommended medical testing on his arm because he felt “ready to go” after taking anti-inflammation medication and tossing a bullpen session on Friday. “I think I know my body best,” the right-hander said. “I’m pretty in tune with my body, and that’s exactly why I refused to take the MRI.”

It’s an unusual decision for a pitcher who has already succumbed to several serious arm issues, some as recent as last season, but as club GM Sandy Alderson told the New York Times’ James Wagner, the Mets aren’t in a position to force the issue.

This is a tense time for the Mets, whose lineup has been fraught with injuries of nearly every variety, from Yoenis Cespedes‘ hamstring issue to Steven Matz‘s elbow inflammation and David Wright‘s cervical disc herniation. Syndergaard’s setback last week didn’t appear too serious, but it would make sense for the team to take things slowly with their best still-healthy hurler. Instead, they’ll push forward on Sunday against the Nationals and hope that Syndergaard’s read on his biceps issue is an accurate one.

The 24-year-old righty is 1-1 through his first four starts of 2017 with a 1.73 ERA, 0.0 BB/9 and 10.4 SO/9 in 26 innings. He’s scheduled to make his first start against the Nationals on Sunday at 1:35 PM ET.